A newly identified genetic marker may significantly improve the ability to predict life-threatening reactions to the gout ...

FRIDAY, Oct. 31, 2025 (HealthDay News) — A new gene test might be able to predict which gout patients will have a bad skin ...

The multi-centre, randomised, double-blind RUBY and TOPAZ studies are assessing the therapy’s performance against allopurinol ...

An expert in gout clinical trials questions whether ethical considerations for such trials need updating to emphasize patient ...

In patients with gout, a novel prediction tool that relies on weight and creatinine clearance successfully identified the ...

These Phase 3 clinical studies are designed to evaluate the safety and efficacy of dotinurad compared to an active control ...

Allopurinol, an inexpensive anti-gout medication, may help stop the progression of colorectal adenomas, according to a news release by the American Association for Cancer Research. Researchers found ...

GLP-1RA use was associated with a lower incidence of rheumatic diseases such as rheumatoid arthritis, gout, and ...

Atom’s lingdolinurad (ABP-671), a URAT1 inhibitor, is in late stage global clinical trials for chronic gout and ABP-745, an anti-inflammatory drug, is in multi-country Phase 2 trials for acute gout ...

Gout causes sudden flares of joint pain, which often arise during the nighttime, and in the big toe, though it may affect other joints including the ankles or knees. It is the most common type of ...

Gout is a type of inflammatory arthritis that causes flare-ups of joint swelling and pain. Kidney disease and gout commonly co-occur and may each contribute to the development of the other. Gout is a ...